Find My Journal

NK

Nicola Kreglinger

New York University US

2

Publications

254

Citations

2

H-Index

1

i10-Index

0

2yr Mean Cite

True

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

2 total

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

H. Gerstein, H. Colhoun, G. Dagenais, R. Diaz, M. Lakshmanan - The Lancet, 2019

Cited by 2,191 Semantic Scholar

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

H. Gerstein, H. Colhoun, G. Dagenais, R. Diaz, M. Lakshmanan - The Lancet, 2019

Cited by 463 Semantic Scholar

Cotranslocational Degradation Protects the Stressed Endoplasmic Reticulum from Protein Overload PDF

Seiichi Oyadomari, Chi Young Yun, Edward A. Fisher, Nicola Kreglinger, Gert Kreibich et al. - Cell, 2006

Cited by 246 OpenAlex

Research Topics

Endoplasmic Reticulum Stress and Disease (2) Genetic Neurodegenerative Diseases (1) RNA regulation and disease (1)

Affiliations

New York University

US 2006 - 2006

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers